127 related articles for article (PubMed ID: 38749558)
61. Evaluation of the Iranian versions of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Patient Acceptable Symptom State (PASS) in patients with ankylosing spondylitis.
Bidad K; Fallahi S; Mahmoudi M; Jamshidi A; Farhadi E; Meysamie A; Nicknam MH
Rheumatol Int; 2012 Nov; 32(11):3613-8. PubMed ID: 22101612
[TBL] [Abstract][Full Text] [Related]
62. Hypovitaminosis D in Patients with Ankylosing Spondylitis: Frequency and Consequences.
Elolemy G; Hassan W; Nasr M; Baraka E
Curr Rheumatol Rev; 2021; 17(4):365-372. PubMed ID: 33687883
[TBL] [Abstract][Full Text] [Related]
63. Gender difference in ASAS HI among patients with ankylosing spondylitis.
Chen HH; Chen YM; Lai KL; Hsieh TY; Hung WT; Lin CT; Tseng CW; Tang KT; Chou YY; Wu YD; Huang CY; Hsieh CW; Huang WN; Chen YH
PLoS One; 2020; 15(7):e0235678. PubMed ID: 32645080
[TBL] [Abstract][Full Text] [Related]
64. Gender-attributable differences in outcome of ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study.
Webers C; Essers I; Ramiro S; Stolwijk C; Landewé R; van der Heijde D; van den Bosch F; Dougados M; van Tubergen A
Rheumatology (Oxford); 2016 Mar; 55(3):419-28. PubMed ID: 26385369
[TBL] [Abstract][Full Text] [Related]
65. Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
Lopalco G; Venerito V; Cantarini L; Emmi G; Salaffi F; Di Carlo M; Tafuri S; Gentileschi S; Di Scala G; Nivuori M; Cacciapaglia F; Galeazzi M; Lapadula G; Iannone F
Clin Exp Rheumatol; 2019; 37(5):762-767. PubMed ID: 31025925
[TBL] [Abstract][Full Text] [Related]
66. Spinal mobility, vertebral squaring, pulmonary function, pain, fatigue, and quality of life in patients with ankylosing spondylitis.
Cho H; Kim T; Kim TH; Lee S; Lee KH
Ann Rehabil Med; 2013 Oct; 37(5):675-82. PubMed ID: 24236255
[TBL] [Abstract][Full Text] [Related]
67. Is there any gender-specific difference in the cut-off values of ankylosing spondylitis disease activity score in patients with axial spondyloarthritis?
Kilic G; Kilic E; Ozgocmen S
Int J Rheum Dis; 2017 Sep; 20(9):1201-1211. PubMed ID: 27309497
[TBL] [Abstract][Full Text] [Related]
68. Clinical performance of ASAS Health Index in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: real-world evidence from Multicenter Nationwide Registry.
Akgul O; Bodur H; Ataman S; Yurdakul FG; Capkin E; Gurer G; Sezer I; Duruoz MT; Melikoglu MA; Cay HF; Rezvani A; Yagci I; Gogus F; Kamanli A; Cevik R
Rheumatol Int; 2020 Nov; 40(11):1793-1801. PubMed ID: 32814986
[TBL] [Abstract][Full Text] [Related]
69. Impact of daily physical therapy over 2 weeks on spinal mobility including objective electronic measurements and function in patients with axial spondyloarthritis.
Kiefer D; Schneider L; Braun J; Kiltz U; Kolle N; Andreica I; Tsiami S; Buehring B; Sewerin P; Herbold S; Baraliakos X
Ther Adv Musculoskelet Dis; 2024; 16():1759720X231224212. PubMed ID: 38404654
[TBL] [Abstract][Full Text] [Related]
70. Construct validity and responsiveness of the simplified version of Ankylosing Spondylitis Disease Activity Score (SASDAS) for the evaluation of disease activity in axial spondyloarthritis.
Salaffi F; Ciapetti A; Carotti M; Gasparini S; Citera G; Gutierrez M
Health Qual Life Outcomes; 2014 Aug; 12():129. PubMed ID: 25146299
[TBL] [Abstract][Full Text] [Related]
71. Upadacitinib for axial spondyloarthritis: a meta-analysis of efficacy and safety.
Tang H; Liu X; Zhao J; Tang Z; Zheng Z; Bai W
Clin Rheumatol; 2024 Jun; ():. PubMed ID: 38874670
[TBL] [Abstract][Full Text] [Related]
72. Construct validity of Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS) treatment target cut-offs in a BASDAI treat-to-target axial spondyloarthritis cohort: a cross-sectional study.
Michielsens C; Bolhuis TE; van Gaalen FA; van den Hoogen F; Verhoef LM; den Broeder N; den Broeder AA
Scand J Rheumatol; 2024 May; 53(3):180-187. PubMed ID: 37339375
[TBL] [Abstract][Full Text] [Related]
73. Development and validation of the Edmonton Ankylosing Spondylitis Metrology Index.
Maksymowych WP; Mallon C; Richardson R; Conner-Spady B; Jauregui E; Chung C; Zappala L; Pile K; Russell AS
Arthritis Rheum; 2006 Aug; 55(4):575-82. PubMed ID: 16874779
[TBL] [Abstract][Full Text] [Related]
74. Biopsychosocial factors should be considered when evaluating central sensitization in axial spondyloarthritis.
Sariyildiz A; Coskun Benlidayi I; Turk I; Zengin Acemoglu SS; Unal I
Rheumatol Int; 2023 May; 43(5):923-932. PubMed ID: 36966430
[TBL] [Abstract][Full Text] [Related]
75. The effects of physical exercise on axial spondyloarthritis - a systematic review.
Pina Gonçalves N; Emília Santos M; Silvério-António M; Donato H; Pimentel-Santos FM; Cruz E
ARP Rheumatol; 2023 Aug; ():. PubMed ID: 37728143
[TBL] [Abstract][Full Text] [Related]
76. Discriminant validity, responsiveness and reliability of the arthritis-specific Work Productivity Survey assessing workplace and household productivity within and outside the home in patients with axial spondyloarthritis, including nonradiographic axial spondyloarthritis and ankylosing spondylitis.
Osterhaus JT; Purcaru O
Arthritis Res Ther; 2014 Aug; 16(4):R164. PubMed ID: 25099160
[TBL] [Abstract][Full Text] [Related]
77. Comparison of Ankylosing Spondylitis Disease Activity Score and Bath Ankylosing Spondylitis Disease Activity Index tools in assessment of axial spondyloarthritis activity.
Wiąk-Walerowicz K; Wielosz E
Reumatologia; 2024; 62(1):64-69. PubMed ID: 38558891
[TBL] [Abstract][Full Text] [Related]
78. Disease Activity As a Major Determinant of Quality of Life and Physical Function in Patients With Early Axial Spondyloarthritis.
Fernández-Carballido C; Navarro-Compán V; Castillo-Gallego C; Castro-Villegas MC; Collantes-Estévez E; de Miguel E;
Arthritis Care Res (Hoboken); 2017 Jan; 69(1):150-155. PubMed ID: 27111872
[TBL] [Abstract][Full Text] [Related]
79. Somatosensory dysfunction related neuropathic pain component affects disease activity, functional status and quality of life in ankylosing spondylitis.
Atar E; Askin A
Int J Rheum Dis; 2020 Dec; 23(12):1656-1663. PubMed ID: 33029922
[TBL] [Abstract][Full Text] [Related]
80. Both ASDAS and ADC are associated with spinal mobility in active axial spondyloarthritis: A comparison between early and later disease.
Chung HY; Chan SCW; Lee KH; Tsang HHL; Ng LL; Lau CS
Int J Rheum Dis; 2022 Mar; 25(3):317-326. PubMed ID: 35019230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
